Galectin‐1, Adiponectin, Leptin, and the Adiponectin to Leptin Ratio as Predictors of Metabolic Syndrome: Influence of Age and Body Mass Index
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/1789457 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 06.04.2026. Verfasst von Darya Saeed Abdulateef und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq, univsul.edu.iq. Hauptthemen laut MEDLINE: Adiponectin, Metabolic Syndrome, Leptin, Galectin 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a multifactorial condition linked to adipose tissue dysfunction and insulin resistance. Emerging evidence highlights the potential roles of adipokines leptin, adiponectin, and galectin‐1 in its pathogenesis. However, studies examining these biomarkers as predictors of MetS, particularly in the context of age and body mass index (BMI), remain limited and inconsistent.
Objective
The objective of this study is to evaluate the association of serum galectin‐1, leptin, adiponectin, and the adiponectin/leptin ratio (A/L) with MetS, and to identify their predictive value across different age and BMI groups.
Methods
In this prospective cross‐sectional study, 122 participants were enrolled and categorized into MetS ( n = 48) and healthy control ( n = 74) groups based on NHLBI/AHA criteria. Anthropometric, clinical, and biochemical parameters were recorded. Serum levels of galectin‐1, leptin, and adiponectin were measured, and the A/L was calculated. Participants were stratified by age (20–39 vs. ≥ 40 years) and BMI (normal, overweight, and obese). Group comparisons, correlation analysis, and binary logistic regression were conducted.
Results
Galectin‐1 and adiponectin levels were significantly lower in the MetS group, whereas leptin levels were not significantly higher. The A/L ratio was significantly lower in the MetS group, particularly among middle‐aged and obese individuals ( p = 0.004). Galectin‐1 correlated positively with adiponectin and the A/L ratio. In logistic regression analysis, A/L emerged as the only independent predictor, with each unit increase reducing the odds of MetS by 8.3%, whereas BMI was a consistent predictor across age groups.
Conclusion
Galectin‐1, adiponectin, and the A/L ratio are associated with MetS, with the A/L serving as a robust independent predictor. These findings underscore the importance of adipokine profiling, particularly in stratified age and BMI groups, for early identification of metabolic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaymaniyah, Iraq, univsul.edu.iq.
ORCID-Profile: Darya Saeed Abdulateef, Trifa Abdalla Mahmood, Lizan Ismail Arkawazi
Zitieren
APA
Abdulateef, D. S., Mahmood, T. A., & Arkawazi, L. I. (2026). Galectin‐1, Adiponectin, Leptin, and the Adiponectin to Leptin Ratio as Predictors of Metabolic Syndrome: Influence of Age and Body Mass Index. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/1789457
Vancouver
Abdulateef DS, Mahmood TA, Arkawazi LI. Galectin‐1, Adiponectin, Leptin, and the Adiponectin to Leptin Ratio as Predictors of Metabolic Syndrome: Influence of Age and Body Mass Index. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/1789457
BibTeX
@article{Abdulateef2026,
author = {Abdulateef, Darya Saeed and Mahmood, Trifa Abdalla and Arkawazi, Lizan Ismail},
title = {Galectin‐1, Adiponectin, Leptin, and the Adiponectin to Leptin Ratio as Predictors of Metabolic Syndrome: Influence of Age and Body Mass Index},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/1789457}
}
EUVIMED